{"id":53275,"date":"2023-01-25T13:02:03","date_gmt":"2023-01-25T12:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/"},"modified":"2023-01-25T13:02:03","modified_gmt":"2023-01-25T12:02:03","slug":"the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/","title":{"rendered":"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5712980\/psoriasis-therapeutics-market-by-drug-class-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=m78vns&amp;utm_campaign=1812618+-+The+Worldwide+Psoriasis+Therapeutics+Industry+is+Estimated+to+Reach+%2455.8+Billion+by+2031+at+a+9.3%25+CAGR&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Psoriasis Therapeutics Market By Drug Class, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230125005456\/en\/1695545\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230125005456\/en\/1695545\/21\/logo.jpg\"><\/a><\/p>\n<p>\nAccording to this report the psoriasis therapeutics market size was valued at $22.9 billion in 2021, and is estimated to reach $55.8 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.\n<\/p>\n<p>\nPsoriasis is a skin disorder that causes skin cells to multiply up to 10 times faster than normal. This makes the skin build up into bumpy red patches covered with white scales. They can grow anywhere, but most appear on scalp, elbows, knees, and lower back. Psoriasis cannot pass from person to person. It does sometimes happen in members of the same family. Psoriasis usually appears in early adulthood.\n<\/p>\n<p>\nFor most people, it affects just a few areas. In severe cases, it can cover large parts of the body. The patches can heal and then come back throughout a person&#8217;s life.\n<\/p>\n<p>\nHowever, there are many treatments. Some slow the growth of new skin cells, and others relieve itching and dry skin. A Doctor selects a treatment plan that is right for patient based on the size of rash, where it is on the body, age, overall health, and other things of patients.\n<\/p>\n<p>\nCommon treatments include steroid creams, moisturizers for dry skin coal tar (a common treatment for scalp psoriasis available in lotions, creams, foams, shampoos, and bath solutions), vitamin D-based cream or ointments, and Retinoid creams.\n<\/p>\n<p>\nMajor factors that drive growth of the global psoriasis therapeutics market include increase in geriatric population, growth in prevalence of plaque and psoriatic arthritis, favorable reimbursement policies, and rise in prescription volume of biological products. In addition, rise in awareness among people regarding different treatments available in the market further propel the market growth.\n<\/p>\n<p>\nHowever, health risks posed, owing to medication along with high costs of therapies restrain growth of the psoriasis therapeutics market during the forecast period. Conversely, increase in development of new biologics and novel pipeline drugs and high growth potential in untapped emerging countries are anticipated to provide lucrative opportunities to the market players.\n<\/p>\n<p>\n<strong>Key Benefits For Stakeholders<\/strong>\n<\/p>\n<ul>\n<li>\nThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the psoriasis therapeutics market analysis from 2021 to 2031 to identify the prevailing psoriasis therapeutics market opportunities.\n<\/li>\n<li>\nThe market research is offered along with information related to key drivers, restraints, and opportunities.\n<\/li>\n<li>\nPorter&#8217;s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.\n<\/li>\n<li>\nIn-depth analysis of the psoriasis therapeutics market segmentation assists to determine the prevailing market opportunities.\n<\/li>\n<li>\nMajor countries in each region are mapped according to their revenue contribution to the global market.\n<\/li>\n<li>\nMarket player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.\n<\/li>\n<li>\nThe report includes the analysis of the regional as well as global psoriasis therapeutics market trends, key players, market segments, application areas, and market growth strategies.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Market Segments<\/strong>\n<\/p>\n<p>\n<strong>By Drug Class<\/strong>\n<\/p>\n<ul>\n<li>\nTNF-alpha Inhibitors\n<\/li>\n<li>\nInterleukin Inhibitors\n<\/li>\n<li>\nDistribution Channel\n<\/li>\n<li>\nHospital Pharmacies\n<\/li>\n<li>\nDrug Stores and Retail Pharmacies\n<\/li>\n<li>\nOnline Providers\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>By Type<\/strong>\n<\/p>\n<ul>\n<li>\nPlaque Psoriasis\n<\/li>\n<li>\nPsoriatic Arthritis\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>By Route of Administration<\/strong>\n<\/p>\n<ul>\n<li>\nOral\n<\/li>\n<li>\nParenteral\n<\/li>\n<li>\nTopical\n<\/li>\n<\/ul>\n<p>\n<strong>By Region<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nUK\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nRest Of Europe\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nRest Of Asia-Pacific\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nLAMEA\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nSouth Africa\n<\/li>\n<li>\nRest Of LAMEA\n<\/li>\n<\/ul>\n<p>\n<strong>Key Market Players<\/strong>\n<\/p>\n<ul>\n<li>\nAbbvie Inc.\n<\/li>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nBausch Health Companies Inc.\n<\/li>\n<li>\nEli Lilly and Company\n<\/li>\n<li>\nJohnson and Johnson\n<\/li>\n<li>\nLEO Pharma\n<\/li>\n<li>\nNovan Inc. (EPI Health LLC)\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nViatris Inc. (Mylan NV)\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5712980\/psoriasis-therapeutics-market-by-drug-class-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=m78vns&amp;utm_campaign=1812618+-+The+Worldwide+Psoriasis+Therapeutics+Industry+is+Estimated+to+Reach+%2455.8+Billion+by+2031+at+a+9.3%25+CAGR&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/o1kv7v<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;&#108;&#x74;&#x6f;&#58;&#x70;&#x72;&#101;&#x73;&#x73;&#64;&#x72;&#x65;&#115;&#x65;&#x61;&#114;&#x63;&#x68;&#97;&#x6e;&#x64;&#109;&#x61;&#x72;k&#x65;&#x74;s&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;r&#x65;&#115;s&#x40;&#114;&#x65;&#x73;e&#x61;&#114;c&#x68;&#97;&#x6e;&#100;m&#x61;&#114;k&#x65;&#116;&#x73;&#46;c&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Psoriasis Therapeutics Market By Drug Class, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. According to this report the psoriasis therapeutics market size was valued at $22.9 billion in 2021, and is estimated to reach $55.8 billion by 2031, growing at &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53275","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Psoriasis Therapeutics Market By Drug Class, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. According to this report the psoriasis therapeutics market size was valued at $22.9 billion in 2021, and is estimated to reach $55.8 billion by 2031, growing at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-25T12:02:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230125005456\/en\/1695545\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-01-25T12:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/\"},\"wordCount\":678,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005456\\\/en\\\/1695545\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/\",\"name\":\"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005456\\\/en\\\/1695545\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-01-25T12:02:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005456\\\/en\\\/1695545\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005456\\\/en\\\/1695545\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Psoriasis Therapeutics Market By Drug Class, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. According to this report the psoriasis therapeutics market size was valued at $22.9 billion in 2021, and is estimated to reach $55.8 billion by 2031, growing at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-25T12:02:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230125005456\/en\/1695545\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR &#8211; ResearchAndMarkets.com","datePublished":"2023-01-25T12:02:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/"},"wordCount":678,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230125005456\/en\/1695545\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/","name":"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230125005456\/en\/1695545\/21\/logo.jpg","datePublished":"2023-01-25T12:02:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230125005456\/en\/1695545\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230125005456\/en\/1695545\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-psoriasis-therapeutics-industry-is-estimated-to-reach-55-8-billion-by-2031-at-a-9-3-cagr-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The Worldwide Psoriasis Therapeutics Industry is Estimated to Reach $55.8 Billion by 2031 at a 9.3% CAGR &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53275"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53275\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}